Robin Hoke

Robin Hoke

Directeur/Membre du Conseil chez
American Aerogel Corp.
Health Technology
Commercial Services
Consumer Services

Profil

Robin Smith Hoke is currently the President & Chief Executive Officer at Leiter's Enterprises, Inc. She is also a Director at American Aerogel Corp.
and Catalyst Clinical Research LLC.
In the past, she served as the President & Chief Executive Officer at Denver Solutions LLC, Chairman at Concord Biosciences LLC, Director at Æterna Zentaris, Inc., Director at Camargo Pharmaceutical Services LLC, Independent Non-Employee Director at Outlook Therapeutics, Inc., and In-House Counsel at Abbott Laboratories.
She was also the Senior Vice President-Global Business Development at Cardinal Health, Inc. and President-Commercial Operations & General Counsel at GeneraMedix Pharmaceuticals, Inc. She was a Partner at Kegler Brown Hill + Ritter Co. LPA and President at GeneraMedix, Inc. Ms. Hoke received her undergraduate degree from Michigan State University in 1984 and her graduate degree from The Thomas M.
Cooley Law School.

Postes actifs de Robin Hoke

SociétésPosteDébut
Directeur/Membre du Conseil 10/09/2020
Directeur/Membre du Conseil -

Anciens postes connus de Robin Hoke

SociétésPosteFin
Directeur/Membre du Conseil 15/05/2020
OUTLOOK THERAPEUTICS, INC. Directeur/Membre du Conseil 11/09/2017
Directeur/Membre du Conseil 01/12/2016
Directeur Général 19/03/2014
Directeur des opérations 04/02/2010
Voir l'expérience en détail de Robin Hoke

Formation de Robin Hoke

Expériences
Fonctions occupées

Actives

Inactives

Sociétés cotées

Entreprise privées

Relations

71

Relations au 1er degré

15

Entreprises liées au 1er degré

Homme

Femme

Administrateurs

Exécutifs

Sociétés liées

Entreprise privées15

Health Technology

Distribution Services

Health Technology

Health Technology

Consumer Services

Commercial Services

Commercial Services

Consumer Services

Process Industries

Commercial Services

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

  1. Bourse
  2. Insiders
  3. Robin Hoke
🔇